At a time when the imminent rate hike in December has once again made investors cautious about its consequences on the investment world, …
The drama between Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan NV (NASDAQ:MYL) continues, this time around in the courts instead of the …
By Garrett Baldwin How Did the Stock Market Do Today? Dow: 17,949.
Teva Pharmaceuticals Industries Ltd (ADR) (NYSE:TEVA) has made an official and unsolicited bid for rival generic drugmaker Mylan NV (NASDAQ:MYL), offering $82/share in a combination …
By Garrett Baldwin The DJIA Index added 27 points Wednesday following a busy day of earnings reports and the release of minutes from …
In a research report issued today, Deutsche Bank analyst Gregg Gilbert maintained a Buy rating on Mylan (NASDAQ:MYL) with a $67 price target, following the …
